- Pathological cut-offs of global and regional brain volume loss in multiple sclerosis2019 | 1. lékařská fakulta
- Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis2021 | 1. lékařská fakulta
- Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis2021 | 1. lékařská fakulta
- Pregnancy-induced brain magnetic resonance imaging changes in women with multiple sclerosis2022 | 1. lékařská fakulta
- "No evident disease activity": The use of combined assessments in the management of patients with multiple sclerosis2017 | 1. lékařská fakulta
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis2021 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?2017 | 1. lékařská fakulta
- Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study A Randomized Clinical Trial2021 | 1. lékařská fakulta
- Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon beta-1a in MS2016 | 1. lékařská fakulta
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | 2. lékařská fakulta, 1. lékařská fakulta
- A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study2017 | 1. lékařská fakulta
- Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings2017 | 1. lékařská fakulta
- Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy2017 | 1. lékařská fakulta
- The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis2018 | 1. lékařská fakulta
- Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis2012 | 2. lékařská fakulta
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis2010 | 2. lékařská fakulta